Royalty Report: Drugs, Pharmaceuticals, Personal Care Products – Collection: 27241

$100.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 3

Primary Industries

  • Drugs
  • Pharmaceuticals
  • Personal Care Products
  • Pain

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 27241

License Grant
We agreed to pay a royalty in connection with our acquisition of the rights to the three original patents for Esterom® solution.  Esterom® solution, a topical formulation for the treatment of conditions involving impaired range of motion.  Impaired range of motion often accompanies injuries and disorders of the shoulder and lower back, as well as other conditions of the joints.  Esterom® solution is derived from a process involving the chemical breakdown of cocaine into new and different molecules, three of which have been patented by us.   We have completed four preclinical animal studies and Phase I and Phase II human clinical trials for Esterom® solution. These trials indicated that Esterom® solution was well tolerated at the dose used.  The Licensor is undisclosed.

IPSCIO Record ID: 27204

License Grant
The Licensor entered into an agreement with an undisclosed Licensee a director of the Company, whereby the Licensor granted the Licensee a non-exclusive right to make, import and use the Licensee's product, Esterom®, under the Licensor's licensed patents and to use the Licensee's confidential information to develop new products that contain the same active ingredients as Esterom®, but are formulated differently.
License Property
Esterom is an investigational drug being studied as a topical analgesic. Chemically, it is a mixture of compounds derived from the esterification of cocaine in propylene glycol.
Field of Use
Esterom®, a topically applied compound for the treatment of impaired range of motion associated with acute lower back sprain and acute painful shoulder.

IPSCIO Record ID: 27076

License Grant
In January 1998, we granted a director of the Company a non-exclusive right for three years to develop both improved products and new products.  Improved products are those that contain the same active ingredients as Esterom® solution, but that are formulated differently.  New products are those which are developed from cocaine or a derivative and are separately patentable.  We will have all rights to the improved and new products.
Field of Use
The rights granted apply to research and development work on Esterom and medical uses (human and animal) of cocaine.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.